Last update 29 Aug 2026

LM-061

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
LM-061
Target
c-Met
Action
inhibitors
Mechanism
c-Met inhibitors(Hepatocyte growth factor receptor inhibitors)
Therapeutic Areas
Congenital DisordersDigestive System DisordersEndocrinology and Metabolic Disease+ [2]
Active Indication-
Inactive Indication
Advanced cancerAdvanced Malignant Solid NeoplasmCongenital Hyperinsulinism
Originator Organization
LaNova Medicines Ltd.LaNova Medicines Ltd.
Active Organization-
Inactive Organization
LaNova Medicines Ltd.LaNova Medicines Ltd.Shanghai LaNova Medicines Research and Development Co Ltd
License Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with LM-061
NCT04882176
/ TerminatedPhase 1/2
A Phase I/II, First-in-Human, Open-Label, Dose-Escalation and Dose-Extension Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of LM-061 Tablet in Subjects With Advanced Tumours
NCT04737122
/ TerminatedPhase 1
A Phase I, First-in-Human, Open-Label, Dose Escalation Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of LM-061 Tablet in Subjects With Advanced Tumors
100 Clinical Results associated with LM-061
Login to view more data
100 Translational Medicine associated with LM-061
Login to view more data
100 Patents (Medical) associated with LM-061
Login to view more data
100 Deals associated with LM-061
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced cancerPhase 2
China
LaNova Medicines Ltd.LaNova Medicines Ltd.
20 May 2021
Congenital HyperinsulinismPhase 2
China
LaNova Medicines Ltd.LaNova Medicines Ltd.
20 May 2021
Advanced Malignant Solid NeoplasmPhase 1
China
Shanghai LaNova Medicines Research and Development Co Ltd
20 May 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free